ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,479Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 387

$682K Total Retail Price of All Prescriptions

Rank: 80 out of 387

458 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

5% of this provider’s 15,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 760 747 1 5
OMEPRAZOLE 610 575 2 4
LEVOTHYROXINE SODIUM 600 588 3 2
LISINOPRIL 552 520 4 3
FUROSEMIDE 515 483 5 7
HYDROCODONE-ACETAMINOPHEN 514 451 S3 6 1
METFORMIN HCL 378 349 7 8
ATENOLOL 371 363 8 20
PAROXETINE HCL 328 324 9 52
WARFARIN SODIUM 283 276 10 17
GABAPENTIN 275 266 11 10
POTASSIUM CHLORIDE 256 250 12 9
PRAVASTATIN SODIUM 254 238 13 15
TRAMADOL HCL 226 185 14 14
CARVEDILOL 222 219 15 21
GLYBURIDE 217 196 R 16 58
HYDROCHLOROTHIAZIDE 213 208 17 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 199 197 18 30
AMLODIPINE BESYLATE 193 189 19 6
ALENDRONATE SODIUM 184 173 20 31
BUSPIRONE HCL 172 167 21 121
CLOPIDOGREL 162 154 22 25
METOPROLOL SUCCINATE 160 154 23 18
DILTIAZEM ER 153 153 24 139
MELOXICAM 148 147 25 22
DOXAZOSIN MESYLATE 145 140 26 75
SPIRONOLACTONE 144 134 27 67
CIPROFLOXACIN HCL 142 130 28 56
LOSARTAN POTASSIUM 140 140 29 24
POLYETHYLENE GLYCOL 3350 136 120 30 57
TAMSULOSIN HCL 129 127 31 32
METOPROLOL TARTRATE 128 128 32 11
RANITIDINE HCL 123 99 33 45
ATORVASTATIN CALCIUM 119 115 34 13
PLAVIX 118 114 35 39
PROMETHAZINE HCL 115 49 R 36 82
TRIAMTERENE-HCTZ 114 105 37 55
FINASTERIDE 111 111 38 95
FENTANYL 111 103 S2 38 80
ENALAPRIL MALEATE 109 109 40 69
FLUTICASONE PROPIONATE 107 98 41 29
PHENYTOIN SODIUM EXTENDED 102 102 42 107
CYCLOBENZAPRINE HCL 102 78 R 42 42
DONEPEZIL HCL 101 91 44 27
FLUOXETINE HCL 96 80 45 46
PRIMIDONE 93 93 46 278
LANTUS 89 67 47 51
ALLOPURINOL 88 88 48 28
PROAIR HFA 86 56 49 47
GUANFACINE HCL 86 82 R 49 244
NYSTATIN 84 82 51 147
NAMENDA 82 69 52 35
TRIAMCINOLONE ACETONIDE 81 73 53 159
DIGOXIN 81 81 53 40
SERTRALINE HCL 80 80 55 23
CEFUROXIME 76 69 56 178
DOXEPIN HCL 75 75 57 323
PREMARIN 75 75 R 57 77
AZITHROMYCIN 74 70 59 49
TRAZODONE HCL 73 65 60 37
PROPRANOLOL HCL 72 72 61 100
NAPROXEN 71 71 62 89
DILTIAZEM 24HR CD 70 70 63 118
CLONIDINE HCL 68 59 64 38
ISOSORBIDE MONONITRATE ER 66 66 65 59
FLUCONAZOLE 65 64 66 160
NITROFURANTOIN MONO-MACRO 65 65 66 197
IBUPROFEN 64 60 68 85
LOVASTATIN 64 64 68 36
LOSARTAN-HYDROCHLOROTHIAZIDE 64 61 68 65
ESTRADIOL 63 54 R 71 105
DETROL LA 63 62 71 178
HYDRALAZINE HCL 62 62 73 94
CARBIDOPA-LEVODOPA 61 61 74 104
CELEBREX 61 52 74 72
CYMBALTA 58 58 76 44
CARISOPRODOL 58 31 R 76 53
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 76 54
NYSTATIN-TRIAMCINOLONE 55 55 79 358
ZOLPIDEM TARTRATE 54 45 80 16
DIOVAN HCT 53 53 81 74
ZETIA 52 52 82 96
CITALOPRAM HBR 52 52 82 19
PREDNISONE 51 47 84 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.